The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.

By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2
via IFTTT
Health
Coronavirus (2019-nCoV), Coronavirus Omicron Variant, Drugs (Pharmaceuticals)
New York Times
April 6, 2022 at 03:14AM